Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip M Becker

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Mayo Clinic Proceedings|September 5, 2013
Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndromeMichael H Silber, Philip M Becker, Christopher Earley, et al.
Clinical Neuropharmacology|January 19, 2011
A 52-week study of gabapentin enacarbil in restless legs syndromeAaron L Ellenbogen, Stephen G Thein, David H Winslow, et al.
Sleep Medicine|October 17, 2017
Identifying clinically important difference on the Epworth Sleepiness Scale: results from a narcolepsy clinical trial of JZP-110Lawrence Scrima, Helene A Emsellem, Philip M Becker, et al.
Sleep|September 30, 2004
Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndromeRichard Allen, Philip M Becker, Richard Bogan, et al.
Journal of Psychosomatic Research|July 21, 2009
The Time of Day Sleepiness Scale to assess differential levels of sleepiness across the dayDiana C Dolan, Daniel J Taylor, Renata Okonkwo, et al.
Mayo Clinic Proceedings|January 7, 2018
The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs SyndromeMichael H Silber, Philip M Becker, Mark J Buchfuhrer, et al.
Sleep|June 6, 2014
Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndromeDiego Garcia-Borreguero, Jeffrey Patrick, Sarah DuBrava, et al.
Clinical Neuropharmacology|August 12, 2009
Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trialArthur S Walters, William G Ondo, Clete A Kushida, et al.
Mayo Clinic Proceedings|July 7, 2018
In Reply-Additional Safety Considerations Before Prescribing Opioids to Manage Restless Legs SyndromeMichael H Silber, Philip M Becker, Mark J Buchfuhrer, et al.
Sleep Medicine|July 23, 2013
A multicenter evaluation of oral pressure therapy for the treatment of obstructive sleep apneaIan M Colrain, Jed Black, Lawrence C Siegel, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Mayo Clinic Proceedings|September 5, 2013
Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndromeMichael H Silber, Philip M Becker, Christopher Earley, et al.
Clinical Neuropharmacology|January 19, 2011
A 52-week study of gabapentin enacarbil in restless legs syndromeAaron L Ellenbogen, Stephen G Thein, David H Winslow, et al.
Sleep Medicine|October 17, 2017
Identifying clinically important difference on the Epworth Sleepiness Scale: results from a narcolepsy clinical trial of JZP-110Lawrence Scrima, Helene A Emsellem, Philip M Becker, et al.
Sleep|September 30, 2004
Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndromeRichard Allen, Philip M Becker, Richard Bogan, et al.
Journal of Psychosomatic Research|July 21, 2009
The Time of Day Sleepiness Scale to assess differential levels of sleepiness across the dayDiana C Dolan, Daniel J Taylor, Renata Okonkwo, et al.
Mayo Clinic Proceedings|January 7, 2018
The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs SyndromeMichael H Silber, Philip M Becker, Mark J Buchfuhrer, et al.
Sleep|June 6, 2014
Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndromeDiego Garcia-Borreguero, Jeffrey Patrick, Sarah DuBrava, et al.
Clinical Neuropharmacology|August 12, 2009
Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trialArthur S Walters, William G Ondo, Clete A Kushida, et al.
Mayo Clinic Proceedings|July 7, 2018
In Reply-Additional Safety Considerations Before Prescribing Opioids to Manage Restless Legs SyndromeMichael H Silber, Philip M Becker, Mark J Buchfuhrer, et al.
Sleep Medicine|July 23, 2013
A multicenter evaluation of oral pressure therapy for the treatment of obstructive sleep apneaIan M Colrain, Jed Black, Lawrence C Siegel, et al.
Pageof 4